QUANZHOU WORUI NEW MATERIALS CO.,LTD., a leader in specialized footwear components, announced its successful showcase of its ...
Discover key elements of insurable risks like measurability and predictability to ensure proper coverage for your assets and ...
In March 2025, The FDA awarded orphan drug designation to Nerlynx® (neratinib) for treating breast cancer patients with brain ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...